- Home
- >
- Investors
Presentation
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
Adocia is a French clinical-stage biotech company. The core activities of the company are to innovate, to discover and to develop new therapeutic solutions to improve the lives of people suffering from chronic metabolic diseases, such as diabetes and obesity.
ADOCIAADOC.PA
4,46%
8,43 €
Source: Forex
Latest press releases
ADOCIA Announces Full Year 2023 Financial Results and Provides a Corporate and Financial Update
04/24/2024
Number of shares and voting rights of ADOCIA as of March 31st, 2024
04/12/2024
ADOCIA Announces a €2 Million Fundraising from its two Main Shareholders and a Member of its Management, and the Signature of an Equity Financing Line with Vester Finance
03/21/2024